Germany
University of Tübingen - Centre for Dermatooncology
nomogram, melanoma, survival, checkpoint inhibitors, anti-PD-1, first line, stage IV
melanoma - access to medicines - disparities - cancer care - immunotherapy - targeted therapy
Squamous Cell Carcinoma, Epidemiology, Cancer Registry Data, Incidence, Anatomical Site, Staging, Histologic subtypes, Primary Tumour